Skip to main content

stock

LITS · Lite Strategy, Inc.

Insiders net bought $12,550 in 90 days; last 8-K filed Nov 3: unregistered share sale.

Follow LITS free

Price

Loading the LITS chart…

Chart by TradingView

The business

What the company does and what it reports, from its SEC filings.

What it is

Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. During fiscal year 2026, we commenced pre-clinical development programs in nononcologic disease indications. We also hold Litecoin (LTC) tokens as a primary reserve asset as part of our broader institutional treasury initiative. We initially built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships, and out-licensing or commercialization, as appropriate. Our approach to pre-clinical drug development is to evaluate our drug candidates either as stand-alone or in combination with standard-of-care therapies to overcome known resistance mechanisms and address medical needs to provide improved patient benefit.

From the 10-K for the fiscal year ended Jun 30, 2026, filed Sep 28, 2026.

Read the 10-K on SEC
Sector
Crypto Assets (SEC office)
Industry
Finance Services (SIC 6199)
Employees
Not stated in the 10-K.
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year ends
June
Exchange
Nasdaq
Fractional shares
No
Listed options
Yes
Filer category
Non-accelerated filer<br>Smaller reporting company
Formerly
MEI Pharma, Inc. (until 2025); MARSHALL EDWARDS INC (until 2012)
Shares outstanding
29,884,653 as of Oct 30, 2026 (XBRL frame )
Filer (SEC EDGAR)
EDGAR filing index

Key stats

Valuation and the ratios that use the live price are free with an account.

Start free to see this

Deep value

NCAV
$4.50M
NCAV per share
$0.15
NNWC
$2.58M
NNWC per share
$0.09

Expectations

Free cash flow
—
Free cash growth, last 5 years
—
Revenue growth, last 5 years
—

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-90.8%
ROA
-88.2%

Health

Current ratio
3.6x
Debt/equity
—

Trailing twelve months to Sep 30, 2026; balance sheet at Sep 30, 2026.

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
Sep 30, 2026——Gross profit: unreported by this company.$14.52M$16.02M
10-Q filed Nov 5, 2026
Jun 30, 2026——Gross profit: unreported by this company.-$11.36M-$13.02M
10-K filed Sep 28, 2026
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Mar 31, 2026——Gross profit: unreported by this company.-$21.61M-$23.69M
10-Q filed May 13, 2026
Dec 31, 2025——Gross profit: unreported by this company.-$29.87M-$30.80M
10-Q filed May 13, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Sep 30, 2025——Gross profit: unreported by this company.-$3.74M-$3.64M
10-Q filed Nov 5, 2026
Jun 30, 2025$0—Gross profit: unreported by this company.-$2.88M-$2.69M
10-K filed Sep 28, 2026
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
Mar 31, 2025$0—Gross profit: unreported by this company.-$2.77M-$2.57M
10-Q filed May 13, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Dec 31, 2024$0—Gross profit: unreported by this company.-$3.45M-$2.68M
10-Q filed May 13, 2026
Assembled from more than one filing; the filing above is only the newest of them.
Cash
$4.28M
Debt
—
Net cash
—
Current assets
$6.20M
Current liabilities
$1.71M
Working capital
$4.50M
Total liabilities
$1.71M
Assets
$58.40M
Equity
$56.70M

Balance as of Sep 30, 2026.

SEC data as of Nov 17, 2026

Earnings moves

ReportReaction day
Jul 30, 2026 Before the openJul 30, 2026
May 13, 2026 Before the openMay 13, 2026
Feb 17, 2026 Before the openFeb 17, 2026

How the price moved after each report: Start free to see this

What happened after past reports, not a forecast. Report dates from SEC 8-K results filings (Item 2.02) since Oct 6, 2025; moves from daily closes.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
Jun 30, 2026—-$66.58M-$71.15M—
Jun 30, 2025$0-$17.45M-$15.95M-$20.84M
Jun 30, 2024$65.30M$14.54M$18.00M-$50.48M
Jun 30, 2023$48.82M-$36.76M-$32.00M-$52.52M
Jun 30, 2022$40.70M-$75.48M-$54.00M-$49.23M
Jun 30, 2021$34.80M-$60.42M-$41.00M-$32.67M
Jun 30, 2020$27.76M-$25.70M-$47.17M$33.36M
Jun 30, 2019$4.92M-$46.24M-$16.82M-$29.64M
Jun 30, 2018$1.62M-$28.59M-$40.07M—
Jun 30, 2017$23.25M$2.38M$2.67M$3.44M

What it filed

Material events and 5% ownership filings from the last year.

Company filings

since Mon Sep 28

events

  • Unregistered share sale
    Nov 38-K
  • Results
    Jul 308-K
  • Regulation FD disclosure
    Jul 248-K
  • Results
    May 138-K
  • Results
    Feb 178-K
  • Executive or director changeShareholder vote results
    Feb 128-K

5% owners ()

Owners and trading

Insider, politician and fund moves, short interest, and the volume traded off the exchange.

Insiders, politicians and funds

Insider trades, last 90 days

  • Glover Nicholas

    Director

    Buy$12,550

    Oct 26, 5:44 PM ET

All insider trades for LITS

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

Short interest

Hard to borrow: Alpaca will not lend it for shorting

  • Shares short

    118,875

  • Of shares outstanding

    0.4%

  • Days to cover

    1.0

  • Change since last report

    +9.5%

Settlement date Oct 30, 2026

Off-exchange short volume, 20 days

36.2%

Through Nov 17, 2026

Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.

Short interest and short volume: FINRA

Off-exchange and dark pools

About 57.5% of shares traded off the exchanges

Period ending Oct 30, 2026, FINRA

Week of Oct 12, 2026, published by FINRA 2 to 4 weeks later

  • Dark pools (ATS)15.9%
  • Wholesalers and other dealers84.1%

Venues, week of Oct 12, 2026

Top dark pools

  1. IATS IBKR ATS52,611
  2. INCR INTELLIGENT CROSS LLC15,853
  3. UBSA UBS ATS11,279
  4. SGMT SIGMA X29,361
  5. LATS THE BARCLAYS ATS7,270

This shows where shares traded, not who bought or sold. Most off-exchange volume is retail orders filled by wholesalers.

Source: FINRA

Members see

  • Signals: which strategies fired on LITS, and the evidence behind each
  • Options positioning: the levels dealers are hedged around
  • Technicals: trend and momentum readings
  • Earnings moves: how the price moved after each report
  • News: stories counted once across outlets
Start free to see these

Comments · 0

No comments yet.

Be the first to say something about LITS.

nakagai

Signals on LITS come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Follow LITS free

Not financial advice. Read the terms that govern posting here.